menu
    • menu

    Company profile for Immunome

    NEW Drugs in Dev: 9
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immunome is developing first-in-class therapeutics to change the way we treat cancer. Our proprietary discovery platform identifies novel therapeutic antibodies, and their targets, by leveraging the “most highly educated” components of the immune systems from patients who have learned to fight off their disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmunomeUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    665 Stockton Drive, Suite 300 Exton, PA 19341
    Telephone
    Telephone
    610.321.3700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.immunome.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/immunome-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/immunome

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Immunome Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
    Immunome Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    06 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-06/immunome-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4

    PHARMIWEB
    06 Feb 2026
    Share Share
    Immunome To Present At Guggenheim Biotech Summit 2026
    Immunome To Present At Guggenheim Biotech Summit 2026

    04 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-04/immunome-to-present-at-the-guggenheim-emerging-outlook-biotech-summit-2026

    PHARMIWEB
    04 Feb 2026
    Share Share
    Immunome Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
    Immunome Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108374499/en/Immunome-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    08 Jan 2026
    Share Share
    Immunome Presents at 44th Annual JPM Healthcare Conference
    Immunome Presents at 44th Annual JPM Healthcare Conference

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106254447/en/Immunome-to-Present-at-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Immunome's Desmoid Tumor Treatment Triumphs in Phase 3
    Immunome's Desmoid Tumor Treatment Triumphs in Phase 3

    16 Dec 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/immunomes-phase-3-desmoid-tumor-treatment-looks-knockout-evercore

    FIERCE BIOTECH
    16 Dec 2025
    Share Share
    Immunome Announces Pricing Of Public Offering Of Common Stock
    Immunome Announces Pricing Of Public Offering Of Common Stock

    16 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251216953878/en/Immunome-Announces-Pricing-of-Public-Offering-of-Common-Stock

    BUSINESSWIRE
    16 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search